Know Labs, Inc. (NYSE:KNW), a leading developer of non-invasive medical diagnostic technology, today announced the publication of its peer-reviewed study inDiabetes Technology & Therapeutics Journaltitled, "A Glycemic Status Classification Model Using a Radiofrequency Noninvasive Blood Glucose Monitor."Diabetes Technology & Therapeuticsis a leading, peer-reviewed journal covering all aspects of diagnosing and managing diabetes with cutting-edge devices, drugs, drug delivery systems, and software.
The published clinical research results demonstrate that Know Labs' proprietary non-invasive radiofrequency (RF) dielectric sensor and trade-secret machine learning (ML) algorithms correctly classified an individual's glycemic status as hyperglycemic...